Alumis, Inc. (ALMS)
7.16
+0.19
(+2.73%)
USD |
NASDAQ |
Oct 09, 16:00
7.165
0.00 (0.00%)
After-Hours: 20:00
Alumis Cash and Short Term Investments (Quarterly) : 502.29M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 502.29M |
| March 31, 2026 | 523.03M |
| December 31, 2025 | 308.58M |
| September 30, 2025 | 377.72M |
| June 30, 2025 | 486.69M |
| March 31, 2025 | 208.75M |
| Date | Value |
|---|---|
| December 31, 2024 | 288.26M |
| September 30, 2024 | 361.87M |
| June 30, 2024 | 209.64M |
| March 31, 2024 | 133.84M |
| December 31, 2023 | 49.06M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Johnson & Johnson | 20.76B |
| Corcept Therapeutics, Inc. | 308.20M |
| Aclaris Therapeutics, Inc. | 91.56M |
| BioAge Labs, Inc. | 318.74M |
| ANI Pharmaceuticals, Inc. | 375.87M |